Stock listing
GENB Stock Price, News, Filings & Events — Generate Biomedicines, Inc.
Selected listing: GENB · NASDAQ · USD · US
This page tracks Generate Biomedicines, Inc.'s GENB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GENB:NASDAQ. GENB:NASDAQ is the stock-level entry point for investors researching Generate Biomedicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Generate Biomedicines, Inc. is a public company listed under the ticker GENB, operating in the American market. The company has a market capitalization of approximately $1.74 billion. Generate Biomedicines focuses on developing innovative biomedicine solutions.
- Ticker
- GENB:NASDAQ
- Asset type
- Stock
- Market cap
- $2.02B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Generate Biomedicines, Inc. GENB:NASDAQ stock context
This page tracks Generate Biomedicines, Inc.'s GENB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GENB:NASDAQ. GENB:NASDAQ is the stock-level entry point for investors researching Generate Biomedicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Generate Biomedicines, Inc. is a public company listed under the ticker GENB, operating in the American market. The company has a market capitalization of approximately $1.74 billion. Generate Biomedicines focuses on developing innovative biomedicine solutions.
Latest news from Generate Biomedicines, Inc.
Generate Biomedicines Inc. to Participate in September Investor Conferences
September 8, 2026
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
May 28, 2026
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 26, 2026
Research Generate Biomedicines, Inc.
Generate Biomedicines, Inc. investor report
Review AI stock analysis and investor report context for GENB:NASDAQ.
Generate Biomedicines, Inc. company profile
View the public company page for Generate Biomedicines, Inc. on 6ix.
Generate Biomedicines, Inc. news
Read company news and market updates connected to Generate Biomedicines, Inc..
Generate Biomedicines, Inc. investor events
Find investor webinars, events, and replay context for Generate Biomedicines, Inc..